Related references
Note: Only part of the references are listed.Thioredoxin-1 Promotes Anti-Inflammatory Macrophages of the M2 Phenotype and Antagonizes Atherosclerosis
Khadija El Hadri et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Peritoneal macrophages are distinct from monocytes and adherent macrophages
Krithika Selvarajan et al.
ATHEROSCLEROSIS (2011)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
Bone morphogenetic protein 7: A broad-spectrum growth factor with multiple target therapeutic potency
Mariette R. Boon et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation
Ine M. J. Wolfs et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages
Fina Lovren et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells
Dinender K. Singla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy
S Wang et al.
KIDNEY INTERNATIONAL (2003)
Atherosclerosis, oxidation and endometriosis
N Santanam et al.
FREE RADICAL RESEARCH (2002)
Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth
H Amthor et al.
DEVELOPMENTAL BIOLOGY (2002)
Share Paper
